SEC Tracker
Get the app

Jazz Pharmaceuticals JAZZ

Planned insider sale of Jazz shares

Bruce C Cozadd, planned sale of Jazz shares

Form
144
Filed
Importance
Routine
  1. Bruce Cozadd to sell 6,000 shares
  2. Acquired via stock option on Mar 5, 2025
  3. Shares sold on Oct 1, 2026, Sep 1, 2026, and Aug 3, 2026
  4. Aggregate market value of $1,295,040

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Jazz Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
  2. Repligen RGEN public float $6.0B, Jun 30, 2025
  3. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  4. Revolution Medicines RVMD public float $6.7B, Jun 30, 2025
  5. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.